Search for: "JANSSEN PHARMACEUTICALS" Results 41 - 60 of 570
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Apr 2010, 2:06 am by Ben Vernia
“The Corporate Integrity Agreement requires Ortho-McNeil-Janssen-Pharmaceuticals, Inc. to increase transparency and accountability and to make changes designed to avoid illegal drug promotion in the future. [read post]
18 Dec 2013, 10:13 pm
The verdicts provide hope for plaintiffs with pending claims, but likely make Janssen Pharmaceuticals very nervous about the extent of liability that the company faces. [read post]
8 Dec 2016, 12:44 pm by Seeger Weiss
The United States Judicial Panel on Multidistrict Litigation (“JPML”) ordered on Wednesday that 55 active suits against the pharmaceutical company Janssen Pharmaceuticals and its parent corporation Johnson & Johnson, be consolidated in the District of New Jersey under Judge Brian R. [read post]
8 Apr 2009, 4:35 am
Pennsylvania is suing Janssen Pharmaceuticals to recover... [read post]
24 Apr 2014, 8:57 am by Pete Strom
Janssen To Pay $5.9 Million Settlement to Montana for Misleading Ads In March of this year, Montana State Attorney General Tim Fox announced that Johnson & Johnson’s subsidiary Janssen Pharmaceuticals agreed to pay $5.9 million to settle allegations in the state regarding its antipsychotic drug, Risperdal. [read post]
17 Jun 2012, 9:55 pm by Patent Docs
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]
15 May 2011, 2:29 pm
Janssen, a subsidiary of pharmaceutical giant Johnson & Johnson (“JJ”) has announced it was cooperating with regulatory authorities in 5 countries to address small amounts of a fungicide found in certain lots of its HIV drug “Prezista. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors… [read post]
4 Dec 2016, 10:11 pm by Michael Baseluos
Moreover, Xarelto defendants like Bayer AG and Janssen Pharmaceuticals touted NOACs and being more effective and safer than Warfarin, employing direct to consumer advertising (DTC). [read post]
4 Nov 2013, 3:04 am by Ben Vernia
Under the FDCA, a pharmaceutical company must specify the intended uses of a drug in its new drug application to the FDA. [read post]
13 Mar 2014, 7:11 pm by CSSFIRM.COM
Topamax is an anti-epilepsy drug marketed by the Johnson & Johnson unit Janssen Pharmaceuticals. [read post]
13 May 2015, 11:38 am by John Suthers
Xarelto (rivaroxaban) is a prescription blood thinner that was developed by pharmaceutical giant Bayer, and marketed by Janssen Pharmaceuticals, a division of another pharmaceutical giant, Johnson & Johnson. [read post]
31 Aug 2016, 1:31 pm by ccladm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
31 Aug 2016, 1:31 pm by ccladm
Janssen Pharmaceuticals, Inc. on May 11th, and ruled that Janssen neglected to make an effort to warn physicians of the risks regarding Topamax. [read post]
18 May 2010, 7:03 pm by Carey, Danis & Lowe
A recent $81 million settlehttp://www.jefflowepc.com/lawyer-attorney-1176136.htmlment between the Department of Justice and Johnson & Johnson's Ortho-McNeil Janssen Pharmaceuticals Inc. means sales reps for the company will be monitored with compliance officers who will observe and report on the representatives' behavior on the job. [read post]
13 Dec 2013, 10:16 am
Ortho-McNeil-Janssen Pharmaceutical is part of a larger mass tort action in the Philadelphia district courts against the makers of Topamax, a drug used to treat epilepsy and migraines. [read post]
23 May 2011, 9:59 pm by Patent Docs
.; Ortho-McNeil-Janssen Pharmaceuticals, Inc. [read post]
25 Mar 2014, 7:52 am by Pete Strom
In 2012, an Arkansas jury agreed that J&J and Janssen Pharmaceuticals misled Arkansas’s doctors regarding Risperdal’s safety. [read post]